LICENSE AGREEMENTS (Details Textual) (USD $)	12 Months Ended		13 Months Ended			0 Months Ended	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Apr. 30, 2012	Dec. 30, 2011	Nov. 09, 2012 Lfb Biotechnologies [Member]	Dec. 31, 2012 Lfb Biotechnologies [Member]	Dec. 31, 2011 Lfb Biotechnologies [Member]	Dec. 31, 2012 Collaboration Agreement [Member]
Stock Issued During Period Shares License Option								132,000
Business Development							$ 31,000,000
Bussiness Acquisiton Purchase Agreement Period Description							The license will terminate on a country by country basis upon the expiration of the last licensed patent right or 15 years after the first commercial sale of a product in such country, unless the agreement is earlier terminated.
Sale of Stock, Number of Shares Issued in Transaction							7,368,000
Contribution Per Licence Agreement In Exchange Of Common Stock							15,000,000
Common Stock Shares Subscribed Subsidiary Sale Of Stock							7,500,000
Shares Issued For Licence Agreement Exchange							7,500,000
Noncash stock expense associated with in-licensing agreement	16,578,000	297,000	16,875,000
Noncontrolling Interest, Description							The Board of Directors of the Company shall nominate a designee names by LFB Group for election at each annual meeting of the stockholders until such time as LFB Group owns less than 10% of the outstanding Company Common Stock.
Milestone Payment									1,000,000
Potential future milestone payments	250,000,000								2,000,000
Upfront Fee Received From Sub License	2,000,000
Licenses Revenue	19,048	0	19,048
Deferred Revenue	1,981,000	0	1,981,000
Additional Amount Receivable On Achievement Of Pre Specified Milestones	5,000,000
Potential Additional Amount Payable On Achievement Of Pre Specified Milestones									182,500,000
Converted Shares						7,500,000
Conversion of Stock, Shares Issued						5,000,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	2,777,962		2,777,962	1,545,396	1,232,381	2,500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 2.25		$ 2.25	$ 2.25	$ 2.25	$ 0.001
Incremental Common Share Attributable To Security Exchange Agreement						750,000
Income taxes	330,000	0	330,000
Current portion of deferred revenue	$ 152,381	$ 0	$ 152,381